The use of photodynamic therapy for skin cancer

Onkologie

Volumn 21, Issue 1, 1998, Pages 20-27

  Karrer, S ^a   Szeimies, R M ^a   Abels, C ^a   Landthaler, M ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

5 Aminolevulinic acid; Photodynamic therapy; Porphyrins; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PURPURIN; TEMOPORFIN;

DRUG MECHANISM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; REVIEW; SKIN CANCER; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031922326     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026783     Document Type: Review

References (47)

1. Von Tappeiner H, Jodlbauer A: Die sensibilisierende Wirkung fluorescierender Substanzen. Gesammelte Untersuchungen uber die photodynamische Erscheinung. Leipzig, FCW Vogel, 1907.
2. Von Tappeiner H, Jesionek A: Therapeutische Versuche mit fluorescierenden Stoffen. Munch Med Wochenschr 1903;47:2042-2044.
3. Auler H, Banzer G: Untersuchungen über die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z Krebsforsch 1942;53:65-68.
4. Meyer-Betz F: Untersuchungen uber die biologische (photodynamische) Wirkung des Hämatoporphyrins und anderer Derivative des Blut- und Gallenfarbstoffs Dtsch Arch Klin Med 1913;112 476-503.
5. Jones LR, Grossweiner LI: Singlet oxygen generation by Photofrin in homogenous and light-scattering media. J. Photochem Photobiol B 1994;26:249-256.
6. Weishaupt KR, Gomer CJ, Dougherty TJ: Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res 1976;36:2326-2329.
7. Kessel D: Sites of photosensitization by derivatives of hematoporphyrin. Photochem Photobiol 1986;44. 489-493
8. Wessels JM, Strauss W, Seidlitz HK, Rück A, Schneckenburger H: Intracellular localization of meso-tetraphenylporphine tetrasulphonate probed by time-resolved and microscopic fluorescence spectroscopy. J Photochem Photobiol B 1992;12: 275-284
9. Milanesi C, Zhou C, Biolo R, Jori G: Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitized tumour necrosis. Br J Cancer 1990;61:846-850
10. Penning LC, Dubbelman TMAR: Fundamentals of photodynamic therapy Cellular and biochemical aspects. Anticancer Drugs 1994;5:139-146.
11. Dellian M, Abels C, Kuhnle GE, Goetz AE: Effects of photodynamic therapy on leucocytc-endothelium interaction: Differences between normal and tumour tissue Br J Cancer 1995;72:1125-1130
12. Star WM, Marijnissen HP, van den Berg Blok AE, Versteeg JA, Franken KA, Reinhold HS: Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 1986;46:2532-2540.
13. Kennedy JC, Pottier RH, Pross DC: Photodynamic therapy with endogenous protoporphyrin IX. Basic principles and present clinical experience. J Photochem Photobiol, B 1990;6:143-148.
14. Szeimies RM, Hein R, Baumler W, Heine A, Landthaler M: A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 1994;74:117-119.
15. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649-1662.
16. Anderson RR, Parrish JA: The optics of human skin. J Invest Dermatol 1981;77:13-19.
17. Webber J, Kessel D, Fromm D: Side effects and photosensitization of human tissues after aminolevulinic acid. J Surg Res 1997;68:31-37.
18. Dougherty TJ: Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol 1981;77:122-124.
19. Buchanan RB, Carruth JAS, McKenzie AL, Williams SR. Photodynamic therapy ia the treatment of malignant tumors of the skin and head and neck. Eur J Surg Oncol 1989;15:400-406.
20. Schweizer VG, Visscher D: Photodynamic therapy for treatment of AIDS-related oral Kaposi's sarcoma. Otolaryngol Head Neck Surg 1990;102:639-649.
21. Kennedy JC, Pottier RH: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol, B 1992;14:275-292
22. Szeimics RM, Sassy T, Landthaler M; Penetration potency of topical applied δ-aminolevulinic acid for photodynamic therapy of basal cell carcinoma Photochem Photobiol 1994;59:73-76.
23. Iinuma S, Farshi SS, Ortel B, Hasan T: A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin. Br J Cancer 1994;79:21-28.
24. Divaris DXC, Kennedy JC, Pottier RH Phototoxic damage to sebaceous glands and hair follicles of mice following systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990;136: 891-897
25. Fritsch C, Verwohlt B, Bolsen K, Ruzicka T, Goerz G: Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism. Arch Dermatol Res 1996;288:517-521.
26. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM: Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996;135:766-771.
27. Oseroff AR, Shanler SD, Buscaglia DA, van Leengoed E, Conti C, Somers K: PDT with topical delta-aminolevulinic acid (ALA) for the treatment of patch and plaque stage cutaneous T-cell lymphoma. Lasers Surg Med Suppl 1995;7:39.
28. Wolf P, Fink-Puches R, Cerroni L, Kerl H: Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 1994;31:678-680.
29. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB: Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer Br J Cancer 1994; 130:743-751.
30. Wolf P, Rieger E, Kerl H: Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid J Am Acad Dermatol 1993;28:17-21.
31. Calzavara-Pinton PG: Repetitive photodynamic therapy with topical delta-aminolevuliaic acid as an appropriate approach to the route treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B 1995;29:53-57
32. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, Berg R, Johansson J, Svanberg S: Photodynamic therapy of non-melanoma malignant tumors of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol 1994;130:743-751.
33. Warloe T, Peng Q, Heyerdahl H, Moan J, Steen HB, Giercksky KE: Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma; in Cortese DA (ed): 5th International Photodynamic Association Biennial Meeting. Proc SPIE 1995;2371:226-235.
34. Orenstein A, Kostenich G, Tsur H, Roitman L, Ehrenberg B, Malik Z: Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, DMSO and EDTA; in Brault D, Jori G, Moan J, Ehrenberg B (eds): Photodynamic Therapy of Cancer II Proc SPIE 1995;2325:100-105
35. Sacchini V, Melloni E, Marchesini R, Fabrizio T, Cascinelli N, Santoro O, Zunino F. Andreola S, Bandieramonte G: Topical administration of tetrasodium-mesotetraphenyl-porphinesulfonate (TPPS) and red light irradiation for the treatment of superficial neoplastic lesions. Tumori 1987;73 19-23
36. Karrer S, Szeimies RM, Hohenleutner U, Heine A, Landthaler M: Unilateral localized basaliomatosis: Treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. Dermatology 1995;190-218-222.
37. Kennedy J: HPD photoradiation therapy for cancer at Kingston and Hamilton. Adv Exp Med Biol 1983;160:53-62.
38. Tse DT, Kersten RC, Anderson RL: Hematoporphynn derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report. Arch Ophthalmol 1984;102:990-994.
39. Feyh J, Goetz A, Müller W, Königsberger R, Kastenbauer E: Photodynamic therapy in head and neck surgery. J Photochem Photobiol B 1990;7:353-358.
40. Wilson BD, Mang TS, Stoll H, Jones C, Cooper M, Dougherty TJ; Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 1992;128-1631-1636.
41. Fijan S, Honigsmann H, Ortel B: Photodynamic therapy of epithelial skin tumours using delta-aminolevulinic acid and desferrioxamine. Br J Dermatol 1995;133: 282-288.
42. Wennberg AM, Lindholm LE, Alpsten M, Larkö O: Treatment of superficial basal cell carcinomas using topically applied delta-aminolevulinic acid and a filtered xenon lamp. Arch Dermatol Res 1996;288:561-564.
43. Cai WM, Yang Y, Zhang NW, Xie JG, Zhang X, Fan XJ, Shen H, Hu XJ, Ha XW: Photodynamic therapy in the management of cancer: An analysis of 114 cases. Adv Exp Med Biol 1985;193:13-19.
44. Pennington DG, Waner M, Knox A: Photodynamic therapy for multiple skin cancers. Plast Reconstr Surg 1987;82:1067-1071.
45. Szeimies RM, Karrer S, Sauerwald A: Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: An initial clinical study. Dermatology 1996;192:246-251.
46. Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TP, Simpson KR, Bukaty LM, Hoffman WL, Fong NL: Photodynamic therapy of actinic keratoses with topical 5-aminolevulinic acid. Arch Dermatol 1997;133: 727-732.
47. Robinson PF, Carruth JAS, Fairris GM. Photodynamic therapy: A better treatment for widespread Bowen's disease. Br J Dermatol 1988;119:59-61.